XML 113 R100.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
INCOME TAXES (Schedule of deferred income tax assets and liabilities) (Details)
$ in Thousands
Dec. 31, 2023
EUR (€)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
USD ($)
Deferred tax assets        
Non-capital loss carryforwards   $ 19,725   $ 20,240
Share issuance costs   847   1,406
Unrealized gains (losses) on investments   5,858   823
Right of use assets   287   614
Fixed assets   77   0
Intangible assets   718   0
Goodwill   7,747   0
Sec 174 - R&D expense   263   0
Other   564   677
Allowance for doubtful accounts   64   0
Gross deferred tax assets   36,150   23,760
Valuation allowance   (36,150)   (20,909)
Total net deferred tax assets   0   2,851
Deferred tax liabilities        
Intangible assets   0   4,094
Lease obligations   0   469
Total deferred tax liabilities   0   4,563
Net deferred tax liabilities   $ 0   $ (1,712)
TruHC Pharma GmbH [Member]        
Deferred tax assets        
Non-capital loss carryforwards | € € 174,000   € 64,000  
Right of use assets | € (154,000)   (179,000)  
Fixed assets | € 8,000   3,000  
Gross deferred tax assets | € 193,000   71,000  
Valuation allowance | € (193,000)   (71,000)  
Total net deferred tax assets | € 0   0  
Deferred tax liabilities        
Lease obligations | € 165,000   183,000  
Net deferred tax liabilities | € € 0   € 0